
Cipla Appoints Chief Executive Officer for One India Business; Announces Stock Option Grants
Cipla Limited has announced a key leadership designation and granted stock options to employees under established incentive schemes, marking significant developments within the company structure. Mr. Shivam Puri, currently the Managing Director and Chief Executive Officer of Cipla Health Limited, was appointed as the Chief Executive Officer for the One India Business and a member of the Management Council, effective July 1, 2026.The appointment formalizes Mr. Puri’s role in leading the One India business segment. He is designated as a Senior Management Personnel at Cipla.
Mr. Puri brings extensive experience to this new capacity. As CEO of Cipla Health, a wholly owned subsidiary, he has been instrumental in expanding its portfolio and strengthening consumer presence across various categories including smoking cessation, pain care, cough and cold, skin care, hair care, and nutrition since taking over the venture in 2019. Under his leadership, Cipla Health has grown into one of India's leading fast moving wellness goods companies over seven years.
With over 23 years of experience across FMCG and healthcare sectors, Mr. Puri possesses strong commercial acumen. Prior to joining Cipla Health, he held senior leadership positions at Hindustan Unilever Limited, Jubilant FoodWorks Limited, and ITC Limited. During his tenure at Hindustan Unilever, he led businesses such as the Pureit water purifier portfolio and Homecare division, delivering growth through operational excellence. Mr. Puri holds a Bachelor of Technology degree from IIT Varanasi (BHU) and an MBA from IIM Lucknow.
In addition to the leadership appointment, Cipla confirmed grants made under the Employee Stock Option Scheme 2013-A and the Cipla Employee Stock Appreciation Rights Scheme 2021. The details regarding these equity incentives are summarized below:
| Scheme | Type of Grant | Number Granted | Vesting/Exercise Period Details |
|---|---|---|---|
| ESOS 2013-A | Stock options | 11,360 | Vesting period is two years from the grant date; exercise period is five years from vesting date. |
| ESAR 2021 | Employee Stock Appreciation Rights (ESARs) | 51,394 | Graded vesting over three years; exercise period is five years from vesting date. |
CIPLA Stock Price Movement
As of 1:13 PM, Cipla Limited shares are slipping by 0.90% in live trading, currently priced at ₹1368.9. The stock has seen a traded volume of 440,785 shares as trading continues in the pharmaceutical company.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.